Role of the NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus Bacteria (NLRP3-Bact)
Sponsor: Centre Hospitalier Universitaire de Nice
Terminated
End of recruitment period
Other terminated trials from Centre Hospitalier Universitaire de Nice
- Diabetic Cardiomyopathies · Phase NA · Dec 2023
- Healthy Volunteers · Phase NA · Jul 2023
- Chronic Kidney Disease · Phase NA · Dec 2022
- Premature Birth · Phase NA · Sep 2022
- Myeloproliferative Disorders · Dec 2020
See all terminations from Centre Hospitalier Universitaire de Nice
A observational or N/A phase clinical study on Escherichia Coli Infections and Staphylococcus Aureus, this trial is terminated or withdrawn. The trial is conducted by Centre Hospitalier Universitaire de Nice and has accumulated 8 data snapshots since 2019. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Aug 2024 — Sep 2024 [monthly]
Terminated
Status: Unknown → Terminated
-
Jul 2024 — Aug 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Oct 2021 — Dec 2021 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
▶ Show 3 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Not Yet Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Apr 2019 — Nov 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Nice
For direct contact, visit the study record on ClinicalTrials.gov .